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T-cadherin is a unique member of the cadherin superfamily that lacks the transmembrane and cytoplasmic do-
mains, and is instead linked to the cell membrane via a glycosyl-phosphatidylinositol anchor. We previously
reported that T-cadherin was specifically expressed on the basal keratinocytes of the epidermis, and the expres-
sion of T-cadherin was significantly reduced in invasive cutaneous squamous cell carcinoma (SCC) and in the
lesional skin of psoriasis vulgaris. In this study, to obtain an insight into the role of T-cadherin in keratinocytes, we
used transfection methods and examined the effect of overexpression or knockdown of T-cadherin in immortalized
keratinocyte cell lines derived from SCC. T-cadherin overexpressed cells showed clearly reduced cell proliferation,
but the inﬂuence of cell–cell adhesiveness and cell mobility was not detected. Using a tetracycline-regulated
expression system, we also conﬁrmed that the suppression of cell proliferation was dependent on the expression
level of T-cadherin. Cell cycle analysis demonstrated that over expression of T-cadherin induced a delay in the G2/M
phase. Our ﬁndings suggest that T-cadherin acts as an endogenous negative regulator of keratinocyte proliferation
and its inactivation is the cause for keratinocyte hyperproliferation in SCC or in psoriasis vulgaris.
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Cadherins are a family of cell adhesion molecules that ex-
hibit calcium-dependent, homophilic binding. Each member
of the cadherins shows specific distribution in various kinds
of organs and is known to be involved not only in cell ad-
hesion but also in many biological processes, such as cell
recognition, cell signaling, cell communication, morpho-
genesis, as well as pathological conditions such as carci-
noma (Angst et al, 2001). It is easy to imagine that a reduced
expression of cadherin triggers the release of carcinoma
cells from the tumor mass. In fact, strong E-cadherin ex-
pression is recognized in well-differentiated carcinomas,
which maintain their cell–cell adhesiveness and are less in-
vasive, but E-cadherin expression is reduced in undifferen-
tiated carcinomas, which have lost their cell–cell adhesion
and show a strong invasive tendency (Hirohashi and Kanai,
2003).
T-cadherin (CDH 13, H-cadherin) is a unique member of
the cadherin superfamily that lacks the transmembrane and
cytoplasmic domains, and is instead linked to the plasma
membrane via a glycosyl-phosphatidylinositol (GPI) anchor
(Ranscht and Dours-Zimmermann, 1991). The fact that the
cytoplasmic domain of classical cadherin is crucial for its
cell–cell adhesion suggests the existence of another func-
tion of T-cadherin (Nagafuchi and Takeichi, 1988; Stappert
and Kemler, 1994; Yap et al, 1998). Furthermore, T-cadherin
does not contain the highly conserved His–Ala–Val motif in
the extracellular domain (Ranscht and Dours-Zimmermann,
1991). Since this motif is crucial for the homophilic interac-
tions of classical cadherin (Blaschuk et al, 1990; Nose et al,
1990), the lack of this motif in T-cadherin also supports this
hypothesis. Like other GPI-anchored proteins, T-cadherin is
enriched in minor detergent-insoluble plasma membrane
domains, called lipid rafts, and co-localizes with signaling
molecules such as Src family kinases (Doyle et al, 1998;
Philippova et al, 1998). These features of T-cadherin indi-
cate that T-cadherin may be involved in signal transduction
rather than cell–cell adhesion.
We previously reported that T-cadherin is expressed on
keratinocytes and is specifically localized in the basal layer
of the epidermis, where keratinocyte proliferation takes
place (Zhou et al, 2002). Furthermore, we also proved that T-
cadherin expression is downregulated in invasive cutane-
ous squamous cell carcinoma (SCC) and in the lesional skin
of psoriasis vulgaris (Takeuchi et al, 2002; Zhou et al, 2003).
Another study showed that T-cadherin suppressed the pro-
liferation of neuroblastoma cells and glioma cells (Takeuchi
et al, 2000; Huang et al, 2003). The function of T-cadherin in
the skin, however, still remains unclear; these results permit
us to speculate that the role of T-cadherin in the skin is the
negative regulation of keratinocyte proliferation, and inac-
tivation of T-cadherin is, conversely, the cause for keratin-
ocyte hyperproliferation.
In this study, to obtain an insight into the role of T-cad-
herin in keratinocytes, we used transfection methods and
examined the effect of overexpression or knockdown of T-
cadherin in immortalized keratinocyte cell lines derived from
SCC. In T-cadherin overexpressing cells, we clearly ob-Abbreviations: SCC, squamous cell carcinoma; Tet, tetracycline
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served reduced cell proliferation, whereas the influence of
cell–cell adhesiveness and cell mobility was not detected.
Using a tetracycline (Tet)-regulated expression system, we
also confirmed that the suppression of cell proliferation was
dependent on the expression level of T-cadherin. Cell cycle
analysis demonstrated that overexpression of T-cadherin
induced a delay in the G2/M phase.
Results
Establishment of T-cadherin overexpressed and down-
regulated cell lines We determined the expression level of
T-cadherin on native HSC-1 cells and the transfectants, the
HSC-1 RNAI cell line (T-cadherin expression is downregu-
lated by the RNAi method), the HSC-1 TCAD cell line (over-
expression of T-cadherin, which is driven by the
cytomegalovirus promoter), and the HSC-1 TCAD RNAI
cell line (overexpressed T-cadherin is downregulated by the
RNAi method), with western blotting (Fig 1a). The results
demonstrated that a weak band was detected from native
HSC-1 cells and no signal was observed from HSC-1 RNAI
(Fig 1a). HSC-1 TCAD showed two thick bands, which were
considered to be mature protein (lower band) and precursor
(upper band) of T-cadherin. These two bands were thinner in
HSC-1 TCAD RNAI, which possessed the characteristic that
the overexpressed T-cadherin was downregulated by the
RNAi method. The expression levels of E-and P-cadherin
were not changed by overexpression or knockdown of T-
cadherin (Fig 1a).
Similar results were obtained from immunofluorescence
staining. HSC-1 cells showed a weak signal, no signal was
detected from HSC-1 RNAI, a stronger signal than the na-
tive HSC-1 cells was detected in HSC-1 TCAD, and a
weaker signal than HSC-1 TCAD was observed in HSC-1
TCAD RNAI (Fig 1b). In HSC-1 cells, it was also demon-
strated that T-cadherin was diffusely distributed on both
cell–cell boundaries and the cell surface (Fig 1b1), whereas
E-and P-cadherin were concentrated mainly at the cell–cell
boundaries (Fig 1b5,6). These observations were similar to
their transfectants (data not shown).
Overexpression of T-cadherin suppressed the prolifer-
ation of HSC-1 To analyze the effect of T-cadherin on cu-
taneous squamous carcinoma cell proliferation, we counted
the native HSC-1 cells, HSC-1 RNAI, HSC-1 TCAD, and
HSC-1 TCAD RNAI, which expressed different levels of T-
cadherin, and compared the difference in proliferation ac-
tivity. HSC-1 cells proliferated well and after 96 h the cell
number increased 13.8 times (Fig 2a). On the other hand,
the T-cadherin overexpressing cell line, HSC-1 TCAD, only
proliferated up to 5.6 times (Fig 2a). HSC-1 TCAD RNAI
restored the proliferation ability of HSC-1 TCAD to 11.1
times (Fig 2a). To know the effect of T-cadherin in native
HSC-1 cells, we compared the proliferation curve of native
HSC-1 cells and HSC-1 RNAI. But the proliferation curve of
HSC-1 RNAI was almost the same as that of native HSC-1
cells (Fig 2a).
Figure 1
The expression level of T-cadherin on HSC-1 and transfectants. (a)
Western blotting of T-, E-, P-cadherin on native HSC-1 (lane 1), HSC-1
RNAI (lane 2), HSC-1 TCAD (lane 3), and HSC-1 TCAD RNAI (lane 4) cell
lysate. Equal amounts of cell lysate were separated by SDS-PAGE, and
then transferred to nitrocellulose membrane. The membrane was in-
cubated with rat monoclonal anti-T-cadherin antibody, TCD-1, mouse
monoclonal anti-human E-cadherin, HECD-1, and mouse monoclonal
anti-human P-cadherin, NCC-CAD-299, and then incubated with HRP-
conjugated secondary antibody. Signals were detected by ECL sys-
tems. (b) Immunofluorescence staining of cadherins on HSC-1 (1, 5, 6),
HSC-1 RNAI (2), HSC-1 TCAD (3), and HSC-1 TCAD RNAI (4). Cells
were immunoreacted with TCD-1 (1–4), HECD-1 (5), and NCC-CAD-
299 (6). Primary antibody was detected by Cy3-conjugated secondary
antibody and examined using a fluorescence microscope. Scale
bar¼ 10 mm.
Figure2
Overexpression of T-cadherin resulted in the suppression of cell
proliferation. Cells were incubated in Dulbecco’s modified Eagle’s
medium containing 1% fetal calf serum for the indicated time period. (a)
Cells were harvested and counted by a Coulter Counter. Results are the
means  SD of three independent experiments performed in triplicate.
po0.01 versus HSC-1, ##po0.01 versus HSC-1 TCAD by the Kruskal–
Wallis rank test with Scheffe’s multiple comparison test. (b, c) Cells
were incubated for 1 h in medium containing tetrazolium salt or BrdU
for WST-1 assay (b) or BrdU incorporation (c), respectively. Results are
the means  SD of five independent experiments. po0.01 versus
HSC-1 by Student’s t test.
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To confirm the difference in the proliferation between
native HSC-1 and T-cadherin overexpressing HSC-1 TCAD,
other proliferation assays were performed. Both the WST-1
cell proliferation assay and BrdU incorporation assay re-
vealed that overexpression of T-cadherin led to the sup-
pression of cell proliferation (Figs 2b and 3c).
Suppression of cell proliferation mediated by T-cad-
herin was dependent on its expression level To analyze
the relationship between cell proliferation and the T-cad-
herin expression level, we used Tet-inducible T-cadherin
overexpressing cells. HSC-1 Trex TCAD showed three
bands, which consisted of the precursor (upper), mature
protein (middle), and a degradation product (lower) of T-
cadherin, and these bands were upregulated by Tet in a
concentration-dependent manner (Fig 3a). Although the
addition of Tet to native HSC-1 cells did not affect cell pro-
liferation, its addition to HSC-1 Trex TCAD suppressed cell
proliferation concentration-dependently, which means the
expression level of T-cadherin negatively regulates cell pro-
liferation in HSC-1 cells. Similar results were obtained using
a different cutaneous squamous carcinoma cell line, DJM-1,
except that only mature T-cadherin was detected in DJM-1
Trex TCAD (Fig 3c,d ). The difference between HSC-1 Trex
TCAD and DJM-1 Trex TCAD was probably due to the
expression efficacy of T-cadherin.
Overexpression of T-cadherin induced a delay in the
G2/M phase of the cell cycle To explore the mechanism of
T-cadherin-mediated downregulation of proliferation, cell
cycle analysis was performed. Both cell lines, native HSC-1
cells and HSC-1 TCAD, showed G1/G0 (2N) synchronization
by serum starvation and a similar pattern of the cell cycle
within 12 h of serum restimulation (Fig 4). Although HSC-1
cells showed a continuous reduction in the number of cells
in the G2/M (4N) phase until 12–24 h after serum restimu-
lation, a larger number of HSC-1 TCAD were still retained in
the G2/M phase at 24 h after serum restimulation (Fig 4).
These results clearly showed that overexpression of T-cad-
herin affects the progress of the cell cycle at the point of G2
or M phase, and consequently delayed the cell cycle.
T-cadherin did not affect either cell aggregation or cell
migration To investigate the effect of T-cadherin on cell–
cell adhesiveness or cell mobility in cutaneous squamous
carcinoma cells, we used HSC-1, HSC-1 RNAI, and HSC-1
TCAD, which expressed a different amount of T-cadherin,
and performed a cell aggregation assay and cell migration
assay. HSC-1 TCAD tended to show a slightly higher ag-
gregation index than native HSC-1, but the difference was
not significant. HSC-1 RNAI exhibited almost the same
rates as native HSC-1 (Fig 5a). In the cell mobility assay,
there was no significant difference in the migration rates
between native HSC-1 and HSC-1 TCAD.
Discussion
The aim of this study was to obtain an insight into the role of
T-cadherin in keratinocytes. We examined the effect of
overexpression or knockdown of T-cadherin in immortalized
keratinocyte cell lines derived from SCC, and the results
clearly demonstrate that T-cadherin negatively regulates the
proliferation of cutaneous squamous carcinoma cells.
Figure 3
T-cadherin suppressed the cell proliferation according to its ex-
pression level. (a, c) Western blotting of T-cadherin on (a) HSC-1 and
tetracycline (Tet)-treated HSC-1 Trex TCAD cell lysate or (c) DJM-1 and
Tet-treated DJM-1 Trex TCAD cell lysate. Cells were incubated in the
presence or absence of various concentrations of Tet for 24 h. Equal
amounts of cell lysate were separated by SDS-PAGE, and then trans-
ferred to a nitrocellulose membrane. The membrane was incubated
with TCD-1 and then incubated with HRP-conjugated secondary an-
tibody. Signals were detected by ECL systems. Tet-induced T-cadherin
over expression in a concentration-dependent manner. (b, d) Effects of
Tet on cell proliferation in (b) HSC-1 and HSC-1 Trex TCAD or (d) DJM-1
and DJM-1 Trex TCAD. Cells were incubated in the presence or ab-
sence of various concentrations of Tet for 96 h, and the number of cells
was counted by a Coulter Counter. Results are the means  SD of
three independent experiments performed in triplicate. po0.01,
po0.05 versus absence of Tet by the Kruskal–Wallis rank test with
Dunnett’s multiple comparison test.
Figure4
T-cadherin-overexpressing cells stayed in G2/M phase for a longer
period than native cells. HSC-1 and HSC-1 Trex TCAD cells were
synchronized at the G1/G0 phase (2N) by serum starvation and then
stimulated with Dulbecco’s modified Eagle’s medium containing 1%
serum for 0, 6, 12, 18, and 24 h. DNA content was measured by a flow
cytometer at each time point. Both HSC-1 and HSC-1 TCAD showed a
slightly reduced distribution of cells in the G1/G0 phase (2N), and in-
creased distribution of cells in the G2/M phase (4N) between 0 and 12
h. Thereafter, HSC-1 cells had a slightly decreased distribution in the
G2/M phase, whereas HSC-1 TCAD cells still had an increased distri-
bution in the G2/M phase between 18 and 24 h.
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We previously reported the loss of T-cadherin expression
in SCC (Takeuchi et al, 2002) and hypothesized that T-cad-
herin was one of the tumor suppressor factors. Similar re-
sults were obtained from breast, lung, ovarian, and bladder
carcinomas (Lee, 1996; Kawakami et al, 1999; Maruyama
et al, 2001; Toyooka et al, 2001). Other studies showed that
T-cadherin suppressed proliferation of glioma cells and ne-
uroblastoma cells (Takeuchi et al, 2000; Huang et al, 2003),
but the function of T-cadherin in cutaneous tissue was still
unclear. In the previous study, we also demonstrated that
the expression of T-cadherin was significantly downregu-
lated in the lesional skin of psoriasis vulgaris (Zhou et al,
2003), which does not exhibit a malignant phenotype, and is
considered to be a T lymphocyte-mediated keratinocyte
hyperproliferative disease. Further, in normal skin tissue, T-
cadherin was specifically localized in the basal layer, where
keratinocyte proliferation takes place (Zhou et al, 2002).
Here, we showed that T-cadherin negatively regulated the
cell proliferation of at least two kinds of immortalized ker-
atinocyte cell lines, HSC-1 and DJM-1, in accordance with
the T-cadherin expression level. This finding suggests that
T-cadherin acts as an endogenous negative regulator of
keratinocyte proliferation at the basal layer of the epidermis.
The epidermis is a constantly self-renewing tissue and bal-
ancing the cell loss from the cornified layer and the cell
division in the basal layer is essential for the maintenance of
skin structure. This regulation is thought to be achieved by
growth control at the basal layer cell including two different
keratinocyte subpopulations: the stem cells and transient
amplifying cells (TAC) (Lavker and Sun, 2000; Watt, 2001).
The relation between T-cadherin and the stem cell or TAC is
a very interesting issue that remains to be elucidated.
The next question is how T-cadherin suppresses the cell
proliferation of cutaneous squamous carcinoma cells. Huang
et al (2003) reported that T-cadherin overexpressing glioma
C6 cells resulted in p21CIP1/WAF1-mediated G2 phase arrest
and aneuploidy (44N) in cells. They also showed that T-cad-
herin overexpressing cells exhibited significantly increased
numbers of cells in the G2/M phase after synchronization by
serum starvation, compared with the vector-transfected cells
that were synchronized in the G1/G0 phase by serum star-
vation. In our studies, T-cadherin overexpressing HSC-1 cells
were able to be induced into the G1/G0 phase by serum
starvation, similar to native HSC-1 cells. After serum restim-
ulation, T-cadherin overexpressing cells resulted in a delay
but not in an arrest at the G2/M phase and there were no
aneuploid cells (44N). Although the precise mechanism of
T-cadherin-mediated suppression of proliferation is still un-
known, it may depend on the difference of cell type. Addi-
tionally, we confirmed that overexpression of T-cadherin
induced no apoptosis in HSC-1 cells (data not shown).
In the epidermis, E- and P-cadherin are the major com-
ponents of intercellular adherence junctions (Nose and
Takeichi, 1986), and are involved in morphogenesis and
maintaining the structure of skin (Hirai et al, 1989). It is re-
ported that the expressions of E- and P-cadherin are re-
duced in SCC, melanoma, and Paget’s disease and
reduction of cadherin expression is considered to be relat-
ed to the detachment of carcinoma cells from the tumor
mass (Shirahama et al, 1996; Furukawa, 1997). The contri-
bution of T-cadherin to keratinocyte cell–cell adhesion, how-
ever, is not yet known. Vestal and Ranscht (1992) showed,
using T-cadherin cDNA-transfected CHO cells, that T-cad-
herin induced calcium-dependent, homophilic adhesion, like
E- or P-cadherin. In our present data from the cell aggre-
gation assay, overexpression of T-cadherin tended to show
slightly increased cell–cell adhesiveness, but the difference
was not significant. In addition, T-cadherin was detected at
both the cell–cell borders and the cell surface, whereas
E- and P-cadherin were concentrated mainly at the cell–cell
borders. These results indicate that the homophilic binding
activity of T-cadherin is relatively weaker than that of E- or
P-cadherin. This phenomenon may be explained by the
specific structure of T-cadherin, which lacks the cytoplasmic
domain and His–Ala–Val motif. So, we concluded that, in the
epidermis, the major function of E- and P-cadherin is cell–
cell adhesion, and that of T-cadherin must be signal trans-
duction or cell recognition, rather than cell–cell adhesion.
In conclusion, this study has provided new information
on the functional significance of T-cadherin in cutaneous
squamous carcinoma cells. T-cadherin negatively regulates
the proliferation of cutaneous squamous carcinoma cells,
and downregulation of T-cadherin may be involved in the
pathogenesis of SCC and psoriasis vulgaris. Further studies
on the expression and regulation of T-cadherin in hyper-
proliferative skin diseases will provide insights into not only
the pathogenesis but also the development of novel ther-
apeutic targets.
Materials and Methods
Cell culture and cell proliferation assay Human cutaneous
squamous carcinoma cell lines, HSC-1 (Kondo and Aso, 1981)
Figure 5
T-cadherin did not affect either cell aggregation or cell migration.
(a) Aggregation assay of HSC-1 cells and transfectants. Cells were
treated with trypsin in the presence of Ca2þ . The cell suspension in
HCMF containing Ca2þ was allowed to aggregate for 20 min at 371C
on a gyratory shaker. Results are the means  SD of the aggregation
index from three independent experiments performed in triplicate.
There was no significant difference between HSC-1 and HSC-1 TCAD
or HSC-1 and HSC-1 RNAI according to the Kruskal–Wallis rank test.
(b) Migration assay of HSC-1 and HSC-1 TCAD cells. Cells were cul-
tured on a colloidal gold particle-coated plate for 24 h. The area where
single cells had migrated was measured. Results are the means  SD
of ten independent cells. There was no significant difference according
to Student’s t test.
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and DJM-1 (Kitajima et al, 1987), were used in this study. The cells
were routinely cultured in Dulbecco’s modified Eagle’s medium
(DMEM) with 10% fetal bovine serum (FBS), 10 ng per mL strep-
tomycin, and 100 units per mL penicillin G at 371C in a humidified
atmosphere of 5% CO2 in air. Cells were trypsinized and subcul-
tured when they were approaching subconfluency. The number of
cells was determined using a Coulter Counter (Beckman Coulter,
Fullerton, California).
To assess the cell proliferation, 2  103 cells per cm2 were
seeded in DMEM containing 1% FBS onto culture dishes for direct
cell counting or 96-well plates for a WST-1 cell proliferation assay
and BrdU incorporation assay. WST-1, which is one of the tetra-
zolium salts, was used to determine cell proliferation according to
the procedure provided by the manufacturer (Takara bio, Shiga,
Japan). The BrdU incorporation assay was performed using a Cell
Proliferation Biotrack ELISA System, ver2 (Amersham Bioscience,
Piscataway, New Jersey) according to the protocol provided with
the kit.
Antibodies The primary antibodies used in this study included the
rat anti-T-cadherin monoclonal antibody, TCD-1, generated in our
laboratory as outlined below. Rats were immunized by injecting
purified glutathione S-transferase (GST) fusion protein containing a
human T-cadherin extracellular domain (residues 210–350) to the
footpad. After the immunization, lymph node cells from the rats
were fused with myeloma cells P3U1 (Matsuyoshi et al, 1997).
Screening was carried out by ELISA, and a hybridoma clone, des-
ignated TCD-1, was established. Its culture supernatant was used
in the following experiments. The mouse anti-human E-cadherin
monoclonal antibody HECD-1 and mouse anti-human P-cadherin
NCC-CAD-299 were also used (Shimoyama et al, 1989). HRP-
conjugated goat anti-rat IgG (DakoCytomation, Glostrup, Den-
mark), HRP-conjugated goat anti-mouse IgG (DakoCytomation),
Cy3-conjugated goat anti-rat IgG (CHEMICON International, Teme-
cula, California), and Cy3-conjugated goat anti-mouse IgG (CHEM-
ICON International) were used as secondary antibodies.
Plasmid constructs Total RNA from HSC-1 cells was purified us-
ing ISOGEN (Nippon Gene, Tokyo, Japan), and cDNA was syn-
thesized by reverse transcriptase Super Scripts II (Invitrogen,
Carlsbad, California) using oligo dT primers. PCR was carried
out to obtain full-length cDNA of human T-cadherin using the
forward primer, 50-cgg gcg ctt cta gtc gga caa aat gca gcc-30,
and reverse primer, 50-agt caa gct tca gac gtc agg agt tct cac-30,
and the product was subsequently cloned to the mammalian
expression vector pIRES neo2 (BD Biosciences Clontech, Palo
Alto, California).
To construct the siRNA-human T-cadherin, the sense template,
50-gat ccc ggt agt cga tag tga cag gtt caa gag acc tgt cac tat cga
cta cct ttt ttg gaa a-30 (italic: BamHI cohesive end, bold: sense
strand, underline: antisense strand); and antisense template, 50-
agc ttt tcc aaa aaa ggt agt cga tag tga cag gtc tct tga acc tgt cac
tat cga cta ccg g-30 (italic: HindIII cohesive end) were annealed and
ligated into a pSilencer 3.1-H1 hygro siRNA expression vector
(Ambion, Austin, Texas).
The pIRESneo2-human T-cadherin was digested with EcoRV
and NotI restriction endonucleases and the insert was ligated to
the appropriate sites of pcDNA 5/TO (Invitrogen), Tet-regulated
expression vector.
All plasmid constructs were confirmed by sequencing using the
ABI PRISM BigDye Terminator cycle sequencing kit (Applied Bio-
systems, Foster City, California).
Transfection The cells were transfected with various plasmid
constructs using lipofectamine plus reagent (Invitrogen).
HSC-1 cells were transfected with human T-cadherin-
pIRESneo2 and selected with 250 mg per mL G418. Single cell
clones were analyzed for T-cadherin expression using western
blotting, and HSC-1 TCAD expressing the highest level of T-cad-
herin was established.
HSC-1 cells and HSC-1 TCAD cells were transfected with hu-
man T-cadherin-siRNA-pSilencer. Cells were selected for 250 mg
per mL hygromycin and screened with western blotting. HSC-1
RNAI and HSC-1 TCAD RNAI with the lowest level of T-cadherin
expression were established.
HSC-1 cells and DJM-1 cells were co-transfected with human
T-cadherin-pcDNA5/TO and pcDNA6/TR (Invitrogen) that express
the Tet repressor. Cells were selected with 250 mg per mL
hygromycin and 5 mg per mL blasticidin double antibiotic resist-
ance, and cultured in the presence or absence of 1 mg per mL Tet
for 48 h. Cell lysates were analyzed with western blotting for T-
cadherin expression; HSC-1 Trex TCAD and DJM-1 Trex TCAD
with Tet-inducible T-cadherin expression were established.
Cell cycle analysis Confluent cells were maintained for 48 h with
serum free medium for G0 synchronization. Then, the cells were
trypsinized, cultured in DMEM containing 1% FBS for 6, 12, 18, 24
h, and collected. The DNA content was determined by a Cycle-
TEST PLUS DNA Reagent Kit (Beckton Dickinson, San Jose, Cal-
ifornia), using the propidium iodide staining method, according to
the instructions provided by the manufacturer. Assays were per-
formed with a flow cytometer (Epics XL-MCL, Beckman Coulter)
and analyzed with EXPO32 software.
Cell aggregation assay Cadherin-mediated cell aggregation was
assayed as described (Matsuyoshi et al, 1992). Briefly, cells were
treated with 0.01% trypsin in the presence of 1 mM CaCl2 at 371C
for 20 min, and then washed with Ca2þ - and Mg2þ -free Hepes-
buffered (pH 7.4) HBSS (HMF) to obtain single-cell suspensions.
5  104 cells in 0.5 mL HMF with 1 mM CaCl2 were incubated in
albumin-coated 24-well plates on a rotary shaker (80 r.p.m.) at
371C for 20 min. The degree of cell aggregation was represented
by the aggregation index (N0N20)/N0, where N0 is the total cell
number per well and N20 is the total particle number per well after
20 min of incubation.
Cell migration assay Cover slips were coated with albumin and
treated with ethanol. After air drying, these cover slips were further
coated with colloidal gold particles as described (Albrecht-Buehler
and Goldman, 1976). 1  103 cells were seeded on these cover
slips placed into six-well plates and cultured for 24 h. Pictures of
the migrated cells were taken and the areas where the cells had
removed the colloidal gold particles were measured with Adobe
Photoshop software (Adobe Systems, San Jose, California).
Immunoﬂuorescence staining The cells cultured on chamber
slides were fixed with PLP (10 mM sodium periodate, 75 mM
lysine, and 2.14 mg per mL paraformaldehyde) for 10 min at room
temperature, followed by blocking with 5% skim milk in 0.01 M pH
7.4 phosphate-buffered saline (PBS) for 30 min at room temper-
ature. The chamber slides were incubated with primary antibody
for 60 min at room temperature. After being washed with PBS three
times, cells were incubated with Cy3-conjugated anti-rat or anti-
mouse secondary antibody diluted with 5% skim milk in PBS for 60
min. The slides were washed again with PBS three times, and
mounted with glycerol. The slides were viewed on a Nikon mi-
crophot-SA fluorescence microscope (Nikon, Tokyo, Japan).
Western blotting Cells were lysed with 2% SDS lysis buffer con-
taining 5%-mercaptoethanol, and boiled for 5 min. Protein con-
centrations were measured by means of the Bio-Rad DC protein
assay (BIO-RAD, Hercules, California). Samples were separated by
SDS-PAGE, followed by transfer to a nitrocellulose membrane
sheet. The membranes were blocked with 5% skim milk in PBS.
After incubation with the primary antibody, the membrane was
washed with PBS for 5 min, three times, and then incubated with
the HRP-conjugated secondary antibody. Signals were detected
by using the ECL system (Amersham Pharmacia Biotech, Buck-
inghamshire, UK).
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Statistical analysis Statistical analyses were performed using
Student’s t test and the Kruskal–Wallis rank test with Scheffe’s
multiple comparison test or Dunnett’s multiple comparison test.
Significance was defined as a value of po0.05.
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